Adherence

Research Update

Can Antidepressants Prolong Survival in Cancer Patients?

From The Carlat Hospital Psychiatry Report, Capacity Assessments

Topics: Adherence | Cancer | Citalopram | Depression | Escitalopram | Fluoxetine | Mortality | Paroxetine | Prozac | Serotonin Specific Reuptake Inhibitors (SSRIs) | Sertraline | SSRIs

Review Of: Shoval G et al, Depress Anxiety 2019;36(10):921–929 Many cancer patients experience depression, especially those with poor prognoses. Compared with euthymic patients, depressed cancer patients are less adherent to their cytotoxic medications, and this poor adherence can worsen their long-term survival. Yet surprisingly, some studies have

Read More
Research Update 1

Can Assertive Treatment Improve Treatment Adherence in Young Adults With Opioid Use Disorder?

From The Carlat Addiction Treatment Report, Alternative Treatment in Addiction

Topics: Adherence | Opioid Use Disorder | Randomized controlled trial | Youth

Review of: Fishman M et al, Addiction 2020 Jul 4. https://doi.org/10.1111/add.15181 We often use injectable extended-release naltrexone (XR-NTX, or Vivitrol) for management of opioid use disorder (OUD). However, XR-NTX has not been widely used in young adults with OUD, possibly due to low patient engagement and treatment adherence. This study evaluat

Read More